Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 12, 2021 09:00 ET | Source: Quotient Limited Quotient Limited Newtown, Pennsylvania, UNITED STATES
JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18.
About Quotient Limited
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platfo
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & .
NeuroneticsFebruary 10, 2021 GMT
MALVERN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Chief Financial Officer, will be participating in a virtual fireside chat as part of the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 17, 2021 at 4:30pm ET.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AVITA Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and .
AVITA MedicalFebruary 3, 2021 GMT
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 17, 2021 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time (February 18, 2021 at 8:30 am Melbourne time).
Share this article
Share this article
TUCSON, Ariz., Feb. 1, 2021 /PRNewswire/ Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time.
A live audiocast of the session will be accessible through the company s investor relations website at
ir.axdx.com. A replay of the audiocast will be available for at least 30 days following the conference.
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for serious infections. The FDA-cleared system and kit fully automate sampl